Valeant's (VRX) new CFO Paul Herendeen is a 'solid' performer and a welcome addition to the beleaguered company, says TheStreet's Jim Cramer. The company announced Monday that Herendeen, an executive at animal healthcare company Zoetis (ZTS) , will replace Robert Rosiello effective immediately. The move is the latest of several management changes at the besieged pharmaceutical company. Rosiello will remain at Valeant as executive vice president of corporate development and strategy. Herendeen has been the CFO of Zoetis since 2014.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.